biosimilars
Cipla to invest Rs 500 crore to set up API facilities
Pharma major Cipla Ltd plans to invest Rs 500 crore for setting up an active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Kurkumbh.
The setting up of these facilities
Biocon seeks marketing alliances in several emerging markets
Bengaluru-based Biocon is planning to forge partnerships as well as leverage existing alliances to augment the access and penetration of its biosimilar molecules.
"We are investing in augmentin
Drug patents expiry to give generic pharma market shot in arm
The patent expiry of several major 'blockbuster' drugs, coupled with other factors, will fuel growth of global generic pharmaceuticals market by 2017, research firm Frost & Sullivan said.
"Immi
